This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kaufman, R J Articles by Kay, R M Search for Related Content PubMed PubMed Citation Articles by Kaufman, R J Articles by Kay, R M

 Previous Article  |  Next Article 

Mol Cell Biol. 1985 July; 5(7): 1750-1759

Coamplification and coexpression of human tissue-type plasminogen activator and murine dihydrofolate reductase sequences in Chinese hamster ovary cells.

ABSTRACT

Expression of human tissue-type plasminogen activator (t-PA) at high levels has been achieved in Chinese hamster ovary (CHO) cells by cotransfection and subsequent coamplification of the transfected sequences. Expression vectors containing the t-PA cDNA gene and dihydrofolate reductase (DHFR) cDNA gene were cotransfected into CHO DHFR-deficient cells. Transformants expressing DHFR were selected by growth in media lacking nucleosides and contained low numbers of t-PA genes and DHFR genes. Stepwise selection of the DHFR+ transformants in increasing concentrations of methotrexate generated cells which had amplified both DHFR genes and t-PA genes over 100-fold. These cell lines expressed elevated levels of enzymatically active t-PA. To optimize both t-PA sequence amplification and t-PA expression, various modifications of the original procedure were used. These included alterations to the DHFR expression vector, optimization of the molar ratio of t-PA to DHFR sequences in the cotransfection, and modification of the methotrexate resistance selection procedure. The structure of the amplified DNA, its chromosomal location, and its stability during growth in the absence of methotrexate are reported.

This article has been cited by other articles:

• Back, S. H., Lee, K., Vink, E., Kaufman, R. J. (2006). Cytoplasmic IRE1{alpha}-mediated XBP1 mRNA Splicing in the Absence of Nuclear Processing and Endoplasmic Reticulum Stress. J. Biol. Chem. 281: 18691-18706 [Abstract] [Full Text]  
• Tzipori, S., Sheoran, A., Akiyoshi, D., Donohue-Rolfe, A., Trachtman, H. (2004). Antibody Therapy in the Management of Shiga Toxin-Induced Hemolytic Uremic Syndrome. Clin. Microbiol. Rev. 17: 926-941 [Abstract] [Full Text]  
• Graves, S. S., Goshorn, S. C., Stone, D. M., Axworthy, D. B., Reno, J. M., Bottino, B., Searle, S., Henry, A., Pedersen, J., Rees, A. R., Libby, R. T. (1999). Molecular Modeling and Preclinical Evaluation of the Humanized NR-LU-13 Antibody. Clin. Cancer Res. 5: 899-908 [Abstract] [Full Text]  
• Wong, G., Temple, P., Leary, A., Witek-Giannotti, J., Yang, Y., Ciarletta, A., Chung, M, Murtha, P, Kriz, R, Kaufman, R., et, al. (1987). Human CSF-1: molecular cloning and expression of 4-kb cDNA encoding the human urinary protein. Science 235: 1504-1508 [Abstract]